Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors

Oncologist - United States
doi 10.1634/theoncologist.2018-0439
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy